← Back to headlines
Grifols Approves IPO for US Biopharma Business
Grifols, a global healthcare company, has officially approved the initial public offering (IPO) of its US biopharma business, signaling a strategic move for the company's future.
24 Mar, 21:42 — 24 Mar, 21:42
Sources
Showing 1 of 1 sources
